NASDAQ: NICE
Nice Ltd Stock

$88.62-2.73 (-2.99%)
Updated Jun 9, 2026
NICE Price
$88.62
Fair Value Price
N/A
Market Cap
$5.36B
52 Week Low
$84.40
52 Week High
$180.61
P/E
10.35x
P/B
1.46x
P/S
2.19x
PEG
0.66x
Dividend Yield
N/A
Revenue
$3.01B
Earnings
$529.63M
Gross Margin
65.8%
Operating Margin
20.72%
Profit Margin
17.6%
Debt to Equity
0.36
Operating Cash Flow
$611M
Beta
1.05
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NICE Overview

NICE Ltd., an Israeli company founded in Ra'anana in 1986, operates globally, specializing in cutting-edge cloud platforms that leverage artificial intelligence for digital business solutions. The company, which changed its name from NICE-Systems Ltd. to NICE Ltd. in June 2016, offers a comprehensive suite of products centered around two primary areas: Customer Experience (CX) and Financial Crime & Compliance. For Customer Experience, NICE's flagship product, CXone, is an open, cloud-native platform designed to power contact centers of all sizes, from small single-site operations to expansive enterprises with distributed remote agents. Supporting this ecosystem, Enlighten is an AI engine dedicated to CX that identifies opportunities for self-service automation. Additional solutions include digital entry points, which assist organizations in addressing consumer demands, and journey orchestration tools that intelligently connect and route customers using real-time AI to efficiently handle their requests. The portfolio further extends to smart self-service capabilities for building data-driven automated conversations, and prepared agent tools that offer real-time guidance and alerts to contact center personnel, ensuring effective issue resolution. Furthermore, its complete performance solutions are designed to capture both structured and unstructured customer interactions and transactional data. In the realm of public safety, NICE Evidencentral provides a digital evidence management platform vital for emergency communications, law enforcement, and the criminal justice system. In the domain of Financial Crime and Compliance, NICE delivers several robust platforms. X-Sight stands out as a flexible, open AI-cloud platform tailored for financial crime and compliance needs, while Xceed offers a cloud-based solution for comprehensive anti-money laundering (AML) and fraud prevention, particularly serving small and mid-sized organizations. Its data intelligence solutions transform raw data into actionable insights for preventing and detecting financial crimes, complemented by AI and analytics technologies that enable real-time detection and prevention. The company also supplies solutions for money laundering and fraud prevention, helping clients adhere to capital markets and AML compliance regulations. Intelligent investigation tools are part of this suite, alongside self-service solutions that grant organizations customization and self-development options for their financial crime prevention strategies.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine NICE's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: App

Industry Rating
B
NICE
Ranked
#83 of 174

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$1.77A
$39.21A
$3.54A
View Top App Stocks

Be the first to know about important NICE news, forecast changes, insider trades & much more!

NICE News

Overview

Due Diligence Score

Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NICE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NICE ($88.62) is trading below its intrinsic value of $89.68, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NICE is good value based on its earnings relative to its share price (10.35x), compared to the US market average (14.33x)
P/E vs Market Valuation
NICE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NICE due diligence checks available for Premium users.

Valuation

NICE fair value

Fair Value of NICE stock based on Discounted Cash Flow (DCF)

Price
$88.62
Fair Value
$249.88
Undervalued by
64.53%
NICE ($88.62) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NICE price to earnings (PE)

For valuing profitable companies with steady earnings

Company
10.35x
Industry
45.69x
Market
14.33x
NICE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NICE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

NICE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.46x
Industry
5.12x
NICE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NICE price to earnings growth (PEG)

For valuing profitable companies with growth potential

NICE is good value based... subscribe to Premium to read more.
PEG Value Valuation

NICE's financial health

Profit margin

Revenue
$768.6M
Net Income
$46.8M
Profit Margin
6.1%
NICE's Earnings (EBIT) of $624.34M... subscribe to Premium to read more.
Interest Coverage Financials
NICE's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$5.0B
Liabilities
$1.3B
Debt to equity
0.36
NICE's short-term assets ($1.30B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NICE's short-term assets ($1.30B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NICE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NICE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$179.2M
Investing
-$39.0M
Financing
-$255.7M
NICE's operating cash flow ($610.72M)... subscribe to Premium to read more.
Debt Coverage Financials

NICE vs App Stocks

TickerZen RatingMarket Cap1d %P/EP/B
NICEC$5.36B-2.99%10.35x1.46x
OTEXA$5.38B-1.60%10.71x1.36x
OCTV$5.32B-9.00%N/A0.69x
LYFTC$5.27B-1.07%1.99x1.74x
ZETAC$5.25B-3.13%-191.64x5.97x

Nice Stock FAQ

What is Nice's quote symbol?

(NASDAQ: NICE) Nice trades on the NASDAQ under the ticker symbol NICE. Nice stock quotes can also be displayed as NASDAQ: NICE.

If you're new to stock investing, here's how to buy Nice stock.

What is the 52 week high and low for Nice (NASDAQ: NICE)?

(NASDAQ: NICE) Nice's 52-week high was $180.61, and its 52-week low was $84.40. It is currently -50.93% from its 52-week high and 5.01% from its 52-week low.

How much is Nice stock worth today?

(NASDAQ: NICE) Nice currently has 60,427,562 outstanding shares. With Nice stock trading at $88.62 per share, the total value of Nice stock (market capitalization) is $5.36B.

Nice stock was originally listed at a price of $21.00 in Dec 31, 1997. If you had invested in Nice stock at $21.00, your return over the last 28 years would have been 322%, for an annualized return of 5.28% (not including any dividends or dividend reinvestments).

How much is Nice's stock price per share?

(NASDAQ: NICE) Nice stock price per share is $88.62 today (as of Jun 9, 2026).

What is Nice's Market Cap?

(NASDAQ: NICE) Nice's market cap is $5.36B, as of Jun 10, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nice's market cap is calculated by multiplying NICE's current stock price of $88.62 by NICE's total outstanding shares of 60,427,562.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.